Back to Search Start Over

Vafseo Approved for Anemia Due to CKD in Patients on Dialysis

Authors :
Park, Brian
Source :
MPR Monthly Prescribing Reference. March 29, 2024
Publication Year :
2024

Abstract

The Food and Drug Administration (FDA) has approved Vafseo[sup.®] (vadadustat) for the treatment of anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at [...]

Subjects

Subjects :
United States. Food and Drug Administration
Hemoglobin
Anemia -- Drug therapy
Chronic kidney failure -- Drug therapy
Darbepoetin alfa
Drug approval
Health

Details

Language :
English
ISSN :
08830266
Database :
Gale General OneFile
Journal :
MPR Monthly Prescribing Reference
Publication Type :
Periodical
Accession number :
edsgcl.788024781

Tools

Authors Abstract Subjects Details